Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 241 | BSL | BLACKSTONE SENI FLTN RAT 202 | Financial Services | 31,759.0 | $411K | 0.11% | -3K | -9.8% | $12.95 | -0.0% |
| 242 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 21,727.0 | $411K | 0.11% | NEW | — | $18.90 | +22.9% |
| 243 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 8,110.0 | $409K | 0.11% | +197.0 | +2.5% | $50.44 | +45.7% |
| 244 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 10,286.0 | $409K | 0.11% | +252.0 | +2.5% | $39.72 | +0.2% |
| 245 | — | BLACKROCK INCOME TR INC | — | 38,229.0 | $404K | 0.11% | -7K | -16.4% | $10.57 | — |
| 246 | MSDL | MORGAN STANLEY DIRECT LENDIN | Financial Services | 28,292.0 | $395K | 0.11% | +2K | +7.7% | $13.96 | +9.9% |
| 247 | BGB | BLACKSTONE STRATEGIC CRED 20 | Financial Services | 35,175.0 | $392K | 0.11% | -7K | -16.3% | $11.15 | +1.9% |
| 248 | BLW | BLACKROCK LTD DURATION INCOM | Financial Services | 30,934.0 | $389K | 0.11% | -5K | -13.8% | $12.59 | -0.9% |
| 249 | NTLA | INTELLIA THERAPEUTICS INC | Healthcare | 30,230.0 | $388K | 0.11% | +737.0 | +2.5% | $12.82 | +5.9% |
| 250 | ADMA | ADMA BIOLOGICS INC | Healthcare | 42,683.0 | $385K | 0.11% | +8K | +23.5% | $9.01 | -10.4% |
| 251 | OXSQ | OXFORD SQUARE CAP CORP | Financial Services | 213,488.0 | $378K | 0.10% | -9K | -4.2% | $1.77 | -23.4% |
| 252 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 29,069.0 | $368K | 0.10% | +708.0 | +2.5% | $12.67 | -31.3% |
| 253 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 40,759.0 | $365K | 0.10% | +995.0 | +2.5% | $8.96 | +4.1% |
| 254 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 11,544.0 | $364K | 0.10% | +281.0 | +2.5% | $31.50 | +5.8% |
| 255 | NCDL | NUVEEN CHURCHILL DIRECT LEND | Financial Services | 28,562.0 | $363K | 0.10% | +1K | +4.0% | $12.72 | +1.8% |
| 256 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 6,188.0 | $360K | 0.10% | +151.0 | +2.5% | $58.15 | -7.2% |
| 257 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 4,984.0 | $359K | 0.10% | +121.0 | +2.5% | $71.95 | -11.7% |
| 258 | PCVX | VAXCYTE INC | Healthcare | 6,126.0 | $356K | 0.10% | +147.0 | +2.5% | $58.11 | -13.5% |
| 259 | PVLA | PALVELLA THERAPEUTICS INC NE | Healthcare | 2,765.0 | $345K | 0.10% | +67.0 | +2.5% | $124.65 | -6.4% |
| 260 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 18,436.0 | $344K | 0.10% | +449.0 | +2.5% | $18.64 | -0.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%